Edition:
United Kingdom

Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

6.85USD
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
$6.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,667
52-wk High
$31.42
52-wk Low
$6.19

Chart for

About

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and... (more)

Overall

Beta: --
Market Cap(Mil.): $1,130.87
Shares Outstanding(Mil.): 41.59
Dividend: --
Yield (%): --

Financials

  DERM.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.65 -- --
ROI: -21.03 8.99 14.48
ROE: -31.39 10.13 15.99

Earnings vs. Estimates